BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31284938)

  • 1. RNA interference and CRISPR: Promising approaches to better understand and control citrus pathogens.
    Goulin EH; Galdeano DM; Granato LM; Matsumura EE; Dalio RJD; Machado MA
    Microbiol Res; 2019 Sep; 226():1-9. PubMed ID: 31284938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR technology to combat plant RNA viruses: A theoretical model for Potato virus Y (PVY) resistance.
    Hameed A; Shan-E-Ali Zaidi S; Sattar MN; Iqbal Z; Tahir MN
    Microb Pathog; 2019 Aug; 133():103551. PubMed ID: 31125685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrus Genetic Engineering for Disease Resistance: Past, Present and Future.
    Sun L; ; Ke F; Nie Z; Wang P; Xu J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 to generate plant immunity against pathogen.
    Zaynab M; Sharif Y; Fatima M; Afzal MZ; Aslam MM; Raza MF; Anwar M; Raza MA; Sajjad N; Yang X; Li S
    Microb Pathog; 2020 Apr; 141():103996. PubMed ID: 31988004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing technologies to fight infectious diseases.
    Trevisan M; Palù G; Barzon L
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas systems versus plant viruses: engineering plant immunity and beyond.
    Ali Z; Mahfouz MM
    Plant Physiol; 2021 Aug; 186(4):1770-1785. PubMed ID: 35237805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoption of CRISPR-Cas for crop production: present status and future prospects.
    Akanmu AO; Asemoloye MD; Marchisio MA; Babalola OO
    PeerJ; 2024; 12():e17402. PubMed ID: 38860212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing plants for virus resistance using CRISPR-Cas.
    Green JC; Hu JS
    Acta Virol; 2017; 61(2):138-142. PubMed ID: 28523919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tweaking genome-editing approaches for virus interference in crop plants.
    Mushtaq M; Mukhtar S; Sakina A; Dar AA; Bhat R; Deshmukh R; Molla K; Kundoo AA; Dar MS
    Plant Physiol Biochem; 2020 Feb; 147():242-250. PubMed ID: 31881433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Viruses: From Targets to Tools for CRISPR.
    Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas-based tools for the targeted control of plant viruses.
    Robertson G; Burger J; Campa M
    Mol Plant Pathol; 2022 Nov; 23(11):1701-1718. PubMed ID: 35920132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering crops of the future: CRISPR approaches to develop climate-resilient and disease-resistant plants.
    Zaidi SS; Mahas A; Vanderschuren H; Mahfouz MM
    Genome Biol; 2020 Nov; 21(1):289. PubMed ID: 33256828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Applications in Plant Virology: Virus Resistance and Beyond.
    Kalinina NO; Khromov A; Love AJ; Taliansky ME
    Phytopathology; 2020 Jan; 110(1):18-28. PubMed ID: 31433273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights of CRISPR technology in human pathogenic fungi.
    Román E; Prieto D; Alonso-Monge R; Pla J
    Future Microbiol; 2019 Sep; 14():1243-1255. PubMed ID: 31625446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.